Elaine Ku1,2,3, Brian K Lee1, Charles E McCulloch3, Garrett R Roll4, Barbara Grimes3, Deborah Adey1, Kirsten L Johansen1,5. 1. Division of Nephrology, Department of Medicine, University of California, San Francisco. 2. Division of Pediatric Nephrology, Department of Pediatrics, University of California, San Francisco. 3. Department of Epidemiology and Biostatistics, University of California, San Francisco. 4. Division of Transplant Surgery, Department of Surgery, University of California, San Francisco. 5. Division of Nephrology, Hennepin Healthcare and Department of Medicine, University of Minnesota, Minneapolis.
Abstract
BACKGROUND: Non-Hispanic black (NHB) and Hispanic patients have lower access to kidney transplantation compared to non-Hispanic whites (NHWs). We examined whether differences in the prevalence of comorbidities that affect eligibility for transplant contribute to disparities in receipt of transplantation. METHODS: We performed a retrospective study of 986 019 adults who started dialysis between 2005 and 2014, according to the United States Renal Data System. We compared prevalence of comorbidities that could influence transplant eligibility by race/ethnicity. We examined time to first transplant by race/ethnicity in this overall cohort and in a very healthy sub-cohort without conditions that could be contraindications to transplantation. RESULTS: During 2.3 years of mean follow-up, 64 892 transplants occurred. NHBs and Hispanics had a lower prevalence of medical barriers to transplantation at the time of dialysis initiation than NHWs, including age >70 years (26% in NHB versus 47% in NHW) and malignancy (4% in Hispanics versus 10% in NHWs). Access to transplant was 65% lower (95% CI, 0.33-0.37) in NHBs and 43% lower (95% CI, 0.54-0.62) in Hispanics (versus NHWs) in the first year after end-stage renal disease, but by Year 4, access to transplantation was not statistically significantly different between Hispanics or NHBs (versus NHWs). In our very healthy cohort, racial and ethnic disparities in access to transplantation persisted up to Year 5 in NHBs and Year 4 in Hispanics after end-stage renal disease onset. CONCLUSIONS: Differences in medical eligibility do not appear to explain racial/ethnic disparities in receipt of kidney transplantation and may mask the actual magnitude of the inequities that are present.
BACKGROUND: Non-Hispanic black (NHB) and Hispanic patients have lower access to kidney transplantation compared to non-Hispanic whites (NHWs). We examined whether differences in the prevalence of comorbidities that affect eligibility for transplant contribute to disparities in receipt of transplantation. METHODS: We performed a retrospective study of 986 019 adults who started dialysis between 2005 and 2014, according to the United States Renal Data System. We compared prevalence of comorbidities that could influence transplant eligibility by race/ethnicity. We examined time to first transplant by race/ethnicity in this overall cohort and in a very healthy sub-cohort without conditions that could be contraindications to transplantation. RESULTS: During 2.3 years of mean follow-up, 64 892 transplants occurred. NHBs and Hispanics had a lower prevalence of medical barriers to transplantation at the time of dialysis initiation than NHWs, including age >70 years (26% in NHB versus 47% in NHW) and malignancy (4% in Hispanics versus 10% in NHWs). Access to transplant was 65% lower (95% CI, 0.33-0.37) in NHBs and 43% lower (95% CI, 0.54-0.62) in Hispanics (versus NHWs) in the first year after end-stage renal disease, but by Year 4, access to transplantation was not statistically significantly different between Hispanics or NHBs (versus NHWs). In our very healthy cohort, racial and ethnic disparities in access to transplantation persisted up to Year 5 in NHBs and Year 4 in Hispanics after end-stage renal disease onset. CONCLUSIONS: Differences in medical eligibility do not appear to explain racial/ethnic disparities in receipt of kidney transplantation and may mask the actual magnitude of the inequities that are present.
Authors: Lauren M Kucirka; Morgan E Grams; Justin Lessler; Erin Carlyle Hall; Nathan James; Allan B Massie; Robert A Montgomery; Dorry L Segev Journal: JAMA Date: 2011-08-10 Impact factor: 56.272
Authors: Harini A Chakkera; Ann M O'Hare; Kirsten L Johansen; Denise Hynes; Kevin Stroupe; Philip M Colin; Glenn M Chertow Journal: J Am Soc Nephrol Date: 2004-11-24 Impact factor: 10.121
Authors: Dorry L Segev; Christopher E Simpkins; Richard E Thompson; Jayme E Locke; Daniel S Warren; Robert A Montgomery Journal: J Am Soc Nephrol Date: 2007-12-19 Impact factor: 10.121
Authors: Elisa J Gordon; Jack O Mullee; Daney I Ramirez; Jessica MacLean; Maria Olivero; Joseph Feinglass; Paula Carney; Kate O'Connor; Juan Carlos Caicedo Journal: Prog Transplant Date: 2014-06 Impact factor: 1.187
Authors: Rachel E Patzer; Sandra Amaral; Haimanot Wasse; Nataliya Volkova; David Kleinbaum; William M McClellan Journal: J Am Soc Nephrol Date: 2009-04-01 Impact factor: 10.121
Authors: Richelle N DeBlasio; Larissa Myaskovsky; Andrea F DiMartini; Emilee Croswell; Donna M Posluszny; Chethan Puttarajappa; Galen E Switzer; Ron Shapiro; Annette J DeVito Dabbs; Amit D Tevar; Sundaram Hariharan; Mary Amanda Dew Journal: Transplantation Date: 2022-04-01 Impact factor: 5.385
Authors: Adrian M Whelan; Kirsten L Johansen; Sandeep Brar; Charles E McCulloch; Deborah B Adey; Garrett R Roll; Barbara Grimes; Elaine Ku Journal: J Am Soc Nephrol Date: 2021-03-12 Impact factor: 10.121
Authors: Tariq U Azam; Hanna Berlin; Elizabeth Anderson; Michael Pan; Husam R Shadid; Kishan Padalia; Patrick O'Hayer; Chelsea Meloche; Rafey Feroze; Erinleigh Michaud; Christopher Launius; Penelope Blakely; Abbas Bitar; Cristen Willer; Rodica Pop-Busui; John M Carethers; Salim S Hayek Journal: Am J Med Date: 2021-11-16 Impact factor: 4.965
Authors: Christine Park; Mandisa-Maia Jones; Samantha Kaplan; Felicitas L Koller; Julius M Wilder; L Ebony Boulware; Lisa M McElroy Journal: Int J Equity Health Date: 2022-02-12